Market Overview

Aimmune Therapeutics (NASDAQ: AIMT)

34.34 +0.01 (0.04%)

Earnings

QuarterPriorEstimateActualSurprise
Q2 2021
After-Hours
EPS:
REV:




Q1 2021
After-Hours
EPS:
REV:
-1.34
575K



Q4 2020
After-Hours
EPS:
REV:
-1.06
0



Q3 2020
After-Hours
EPS:
REV:
-1.03
0



Q2 2020
After-Hours
EPS:
REV:
-1.01
0
-1.09
1.33M
-1.06
0
2.75%
-100%
Q1 2020
After-Hours
EPS:
REV:
-0.75
0
-1.18
1.34M
-1.34
575K
-13.56%
-57.09%
Q4 2019
After-Hours
EPS:
REV:
-0.95
-1.06
-1.06
0
0%
Q3 2019
After-Hours
EPS:
REV:
-0.89

-1.03
0

Q2 2019
After-Hours
EPS:
REV:
-0.91
0
-0.94
-1.01
0
-7.45%
Q1 2019
After-Hours
EPS:
REV:
-0.92
0
-0.97
-0.87
0
10.31%

Data powered by Benzinga Pro Calendars - Start your FREE TRIAL today!